Articles
-
Oct 9, 2024 |
onclive.com | Kimmie Ng
CommentaryVideoOctober 9, 2024Author(s):Kimmie Ng, MD, MPH, discusses treatment considerations for younger patients with colorectal cancer. Kimmie Ng, MD, MPH, associate chief, Division of Gastrointestinal Oncology, director, Young-Onset Colorectal Cancer Center, co-director, Colon and Rectal Cancer Center, physician, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School, discusses treatment considerations for younger patients with colorectal cancer.
-
Sep 30, 2024 |
onclive.com | Kimmie Ng
Kimmie Ng, MD, MPH, associate chief, Division of Gastrointestinal Oncology, director, Young-Onset Colorectal Cancer Center, co-director, Colon and Rectal Cancer Center, physician, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School, discusses factors of consideration when approaching later-line treatment decisions for patients with refractory metastatic colorectal cancer (mCRC).
-
Sep 26, 2024 |
onclive.com | Kimmie Ng
CommentaryVideoSeptember 26, 2024Author(s):Kimmie Ng, MD, MPH, discusses the addition of vitamin D to standard chemotherapy plus bevacizumab in patients with untreated metastatic colorectal cancer.
-
May 1, 2024 |
medscape.com | Benjamin L. Schlechter |Kimmie Ng
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Benjamin L. Schlechter, MD: Hello. I'm Dr Benjamin Schlechter. Welcome to Medscape's InDiscussion series on colorectal cancer.
-
Dec 4, 2023 |
nature.com | Shahabbedin Sotudian |Xintao Qiu |Renee Maria Saliby |Rong Li |Cindy H Chau |James A. DeCaprio | +14 more
Correction to: Nature Medicine https://doi.org/10.1038/s41591-023-02605-z, published online 21 October 2023. This article was originally published under a standard Springer Nature license (© The Author(s), under exclusive licence to Springer Nature America, Inc.); it is now available as an open-access paper under a Creative Commons Attribution 4.0 International license, © The Author(s). The error has been corrected in the HTML and PDF versions of the article.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →